Join to view full profile
800 Howard AveFl 1New Haven, CT 06519
Phone+1 203-785-2815
Fax+1 203-737-7618
Dr. Kim is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am a board certified urologist with clinical and research focus on prostate and kidney cancer. To date, I have performed over 2200 robotic prostatectomies and 200 laparoscopic/robotic nephrectomies. My clinical and research interest is in high-risk and metastatic prostate cancer with the focus on the role of surgery. In addition, I am investigating treatment resistance mechanism in prostate cancer and have jointly developed candidate molecules that target the androgen signaling pathway. My research activity has resulted in more than 190 publications and funding support from the Department of Defense and various philanthropic organizations.
Education & Training
The Wharton School of the University of PennsylvaniaMBA, Management, 2015 - 2017
University of California (Irvine)Fellowship, Minimally Invasive Urologic Surgery, 2003 - 2005
Baylor College of MedicineResidency, Urology, 1999 - 2003
National Cancer InstitutePost-Doctoral Fellowship, 2000 - 2001- Baylor College of MedicineInternship, Transitional Year, 1997 - 1998
Certifications & Licensure
CA State Medical License 2003 - Present
FL State Medical License 2021 - Present
CT State Medical License 2021 - 2027
NJ State Medical License 2005 - 2027
American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification ARIA Oncology Information System (for Medical Oncology), Varian Medical Systems, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification Patient Engagement Portal, Navigating Cancer, Inc., 2013-2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification ARIA oncology information system (for Medical Oncology), Varian Medical Systems, 2013-2014, 2016-2017
Clinical Trials
- Collecting and Storing Blood and Tumor Tissue Samples From Patients Undergoing Prostatectomy or Transurethral Resection of the Prostate Start of enrollment: 2008 Dec 12
- S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery Start of enrollment: 2011 Apr 01
- Androgen Receptor Antagonist ARN-509 With or Without Abiraterone Acetate, Gonadotropin-Releasing Hormone Analog, and Prednisone in Treating Patients With High-Risk Prostate Cancer Undergoing Surgery Start of enrollment: 2017 Jun 20
Publications & Presentations
PubMed
- 2 citationsFace/off: phase-specific modeling of lineage plasticity using near-patient models in genitourinary cancers.Zirui Fu, Longjun Li, Curtis J Perry, Fady Ghali, Wei Shen Tan
Gene. 2026-11-10 - Mirror worlds: The shared regulatory architecture of cell fate in development and cancer.Melanie Fraidenburg, Longjun Li, Rosa Kwon, Fady Ghali, Joshua Warrick
Cancer Letters. 2026-10-28 - Mortality in Medicare-aged Men With Metastatic Prostate Cancer After the Introduction of Androgen Receptor Pathway Inhibitors: A Population-based Study.Isaac E Kim Jr, Rebecca Hartman, Krupa Gandhi, Nikita Nikita, Joshua Banks
Urology. 2026-09-01
Journal Articles
- Trends and Outcomes of Lymphadenectomy for Nonmetastatic Renal Cell Carcinoma: A Propensity Score-Weighted Analysis of the National Cancer DatabaseParth K Modi, Tina M Mayer, Isaac Y Kim, Sammy E Elsamra, Thomas L Jang, Eric A Singer, Urologic Oncology
- Cytoreductive Prostatectomy: Evidence in Support of a New Surgical ParadigmIzak Faiena, Eric A. Singer, Chris Pumill, and Isaac Y. Kim, Int J Oncology, 1/1/2014
- Factors related to patient-perceived satisfaction after robot-assisted radical prostatectomy based on the expanded prostate cancer index composite surveyJeong Hyun Kim, Yun-Sok Ha, Seong Jin Jeong, Wun-Jae Kim, Thomas L. Jang, and Isaac Yi Kim, Prostate Cancer and Prostatic Disease, 1/1/2013
Books/Book Chapters
Abstracts/Posters
- Prostate cancer bone metastases acquire resistanct to androgen deprivation via WNT5A medicated BMP-6 inductionIsaac Yi Kim, Urological Research Society Annual Meeting, Munich, Germany, 1/18/2014
- Active Surveillance for Prostate Cancer: Rethinking Prostate-Specific Antigen Density Eligibility CriteriaYunsok Ha, Neal Patel, Amirali Salmasi, Eric Singer, Jihyeong Yu, Jeong Hyun Kim, Wun-Jae Kim, Isaac Yi Kim, 109th annual meeting of the American Urological Association, Orlando, FL, 1/16/2014
- Off-target Effect of Sildenafil is Neuroprotective via Phosphodiesterase Type-4Amirali Salmasi, Neal Patel, Geun Taek Lee, Isaac Yi Kim, 109th annual meeting of the American Urological Association, Orlando, FL, 1/16/2014
Lectures
- Indications for adjuvant radiation following RARP at Rutgers-CINJSeoul, Korea - 1/7/2015
- Prostate cancer bone metastases acquire resistance to androgen deprivation via Wnt5a mediate BMP6 inductionVancouver, Canada - 1/19/2014
- Wnt5A/BMP-6 Loop and Castration Resistance in Prostate Cancer Bone MetastasesDallas, TX - 1/16/2014
Other
- Robot-Assisted Laparoscopic Radical ProstatectomyIsaac Y. Kim
1/20/2010 - Laparoscopy 1Isaac Y. Kim, 26th World Congress Endourology and SWL
Shanghai, China - 1/30/2008 - Expression and Regulation of Transforming Growth Factor-B Receptors in Normal and Malignant Prostatic Epithelial CellsIsaac Y. Kim, University Microfilm Inc Dissertation Services
1/1/1996
Press Mentions
Prostate Cancer Deaths to Decrease, Yale Researchers PredictMarch 9th, 2026- Community Collaboration Supports Prostate Cancer Rally in New HavenJanuary 5th, 2026
- Breakthrough Study in Image-Guided Prostate Cancer TreatmentMarch 25th, 2025
Professional Memberships
- Member
Other Languages
- Korean
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: